Position in BMY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,968,356
-$24,906 QoQ
Shares Held
34,161
+3.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#843
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EXCALIBUR MANAGEMENT CORP holds $32,863,371 across 10 Drug Manufacturers - General names. BMY ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,287 | $9,469,779 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,387 | $6,731,729 | |
| 3 | PFE |
Pfizer Inc
|
155,777 | $3,751,110 | |
| 4 | ABBV |
AbbVie Inc.
|
13,505 | $3,398,398 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,349 | $2,697,232 | |
| 6 | AMGN |
Amgen Inc
|
6,407 | $2,320,102 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
34,161 | $1,968,356 | |
| 8 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,968,356 | 34,161 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,993,262 | 32,865 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,774,410 | 32,896 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,391,740 | 30,859 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,466,513 | 31,681 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,995,714 | 32,722 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,835,315 | 32,449 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,700,124 | 32,859 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,314,050 | 31,641 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,379,719 | 25,442 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,135,131 | 22,123 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,220,987 | 21,037 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,271,070 | 19,876 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,373,793 | 19,821 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,403,960 | 19,513 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,428,980 | 20,101 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,546,776 | 20,088 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $1,746,950 | 23,921 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,497,148 | 24,012 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,196,831 | 20,227 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,266,706 | 18,957 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,184,129 | 18,757 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,107,793 | 17,859 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,051,216 | 17,436 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,034,997 | 17,602 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $994,791 | 17,847 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||